InvestoGain

Investogain Pty Limited
AFS Licence No. 334036

All correspondence to:
admin@delisted.com.au
or by mail to:
PO Box 400
Crows Nest NSW 1585

26 April 2025

Name:	CELLESTIS LIMITED (CST)
Date of Listing:	24 April 2001
Date of Delisting:	30 August 2011

Stock Exchange Status: (updated daily)

This entity was delisted from the Australian Securities Exchange on 30 August 2011.

Legal Status: (updated monthly)

To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. We have not therefore verified the current legal status of this entity. If you have questions about your shareholding, as we say elsewhere, they may be taken up here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.

Capital Gains Tax (CGT) Status: (updated at least quarterly)

To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. You will need to seek independent tax advice in relation to Capital Gains Tax or other tax matters but any other enquiries relating to your shareholding in the company should be followed up via our online form here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.

Updates, corrections, disagreements please email to admin@delisted.com.au

Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.

Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.

Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.

CELLESTIS LIMITED(CST)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

Shareholder links

Our website ranking of CST:

(2 out of 5)

COMPANY WEBSITE:

CST website

CST email

CST directors

REGISTRY:

Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067

Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

Address: Level 1, Office Tower 2 Chadstone Centre 1341 Dandenong Rd Chadstone, VIC 3148
Tel: + 61 3 8527 3500 Fax: + 61 3 9568 6623

Date first listed: 24/04/2001
Company Secretary:
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Research, develop and market QuantiFERON technology products for medical diagnosis and scientific research - the QuantiFERON technology is a patented whole blood method for detecting cell mediated immune responses using whole blood samples

News & Events

Expand this box to read and print

delisted at the request of the Company under listing rule 17.11, following confirmation of the implementation of the scheme of arrangement by which QIAGEN Australia Holding Pty Ltd is now the sole shareholder in the Company	30/08/2011
we understand Cellestis shareholders received Scheme Consideration of $3.74 per Cellestis share from QIAGEN Australia Holding Pty Ltd and a Special Dividend of $0.06 per Cellestis Share, together representing Total Cash Payments of $3.80 per Cellestis share	30/08/2011
the securities of Cellestis Limited (the "Company") will be suspended from quotation at the close of trading today, 10 August 2011, at the request of the Company, following lodgement with ASIC of the court order approving the scheme of arrangement between the Company and its shareholders to effect the acquisition of the Company by QIAGEN Australia Holding Pty Limited	10/08/2011
we understand that on or about this date the company undertook, proposed to undertake or was the subject of the following corporate action: - Qiagen Australia Holdings Pty Limited to acquire shares - this corporate event may appear elsewhere in this company record	28/07/2011

ASX Announcements (courtesy of ASX)

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

Company Updates

Post your comments here

Please read our Terms before posting comments.

Click here for free access to this company's:
ASX, Legal & CGT Status

Directors' on-market share transactions (last 5)

Click here for the last 20 transactions all companies

Directors & Executives (current)

NAME	TITLE	DATE OF APPT
Ronald Pitcher	Chairman
Anthony Radford	Managing Director
Brian Manuel	CFO, Company Secretary
John Bennetts	Director
Antonino Catanzaro	Director
James Rothel	Director

Date of first appointment, title may have changed.

Directors & Executives (former)

NAME	TITLE	DATE OF APPOINTMENT	DATE OF RESIGNATION

Date of first appointment, title may have changed.